21/10/2017
During EANM 2017, ORA™ is launching NEPTIS® xSeed™, a versatile kitless synthesizer for accelerating the development of new tracers and their seamless transfer to GMP production.
Philippeville, Belgium, October 21th 2017 / Optimized Radiochemical Applications (ORA™) today announced the effective launch and availability early 2018 of its new NEPTIS® xSeed™ kitless synthesizer, a versatile synthesizer for the development of new tracers and their seamless transfer to GMP production. Tracer production is increasingly evolving towards the use of automated synthesis modules with […]
15/10/2016
ORA™ is launching NEPTIS® Designer, a revolutionary tool for tracers development, during EANM 2016
Philippeville, Belgium, October 15th 2016 / Optimized Radiochemical Applications (ORA™) today announced the effective launch and availability of its new NEPTIS® Designer application software, a revolutionary 3D virtual reality tool for the development of new tracers. With the market evolution of PET tracers, the new challenge, especially for academics and researchers, is how to be […]
06/06/2015
ORA™ reveals in world premiere its new NEPTIS® Nx3™ triple run synthesizer during SNNMI-2015
Philippeville, Belgium, June 6th 2015 / Optimized Radiochemical Applications (ORA™) today announced it is presenting as a world premiere its new NEPTIS® Nx3™ triple independent run synthesizer for an optimized and cost-effective production of FDG radiopharmaceutical. To succeed in a highly competitive market place, commercial PET tracer centers are facing the paradigm of increasing their […]
28/04/2014
ORA™ has obtained the ISO13485 certification for Medical Devices
Philippeville, Belgium, June 7th 2014 / Optimized Radiochemical Applications (ORA™) today announced that it has obtained the ISO 13485 certification for Medical Devices. In October 2010, ORA was selling its first NEPTIS synthesizer in the US. Since then, the company has manufactured and installed over 100 NEPTIS synthesizers worldwide. In 2013, ORA has expanded its […]
19/10/2013
ORA™ releases a new add-on semi-preparative module to extend synthesis possibilities of its already revolutionary and industry-most compact PET synthesizer: the NEPTIS® mosaic-SP
Philippeville, Belgium, June 19th October 2013 / Optimized Radiochemical Applications (ORA™) today announced the release of its new NEPTIS® mosaic-SP module. This semi-preparative module is an add-on to the NEPTIS® mosaic-LC. This latest revolutionary module was presented for the first time and commercially launched during SNMI2013 in Vancouver earlier this year. Both these modules are […]
29/07/2013
ORA™ and CycloSmith have concluded collaboration agreement for reinforcing ORA™ technical support for the customers of its NEPTIS® synthesizers in North America
Philippeville, Belgium, July 29th 2013 / Optimized Radiochemical Applications (ORA™) and CycloSmith LLC (Clemmons, North Carolina, USA) have today announced that they have concluded a colloration agreement for reinforcing ORA™ technical support for the customers of its NEPTIS® synthesizers in North America. ORA™ innovative range of NEPTIS® synthesizers were on display at the Society for […]
08/06/2013
ORA™ releases it new patented technology – WNE® system – the founding stone of a revolutionary range of innovative and ultra-reliable PET synthesizers
Philippeville, Belgium, June 8th June 2013 / Optimized Radiochemical Applications (ORA™) today announced the release of its new patented technology: WNE® system. This technology allows the design of 3-position pneumatic actuator that will be equipping the new 2013 range of NEPTIS® synthesizers: NEPTIS® perform, NEPTIS® mosaic-RS and NEPTIS® mosaic-LC. Recent trends in the development of […]
08/06/2013
NEPTIS® synthesizer from ORA™ selected as a manufacturing platform for Eli Lilly’s AMYVID™
Philippeville, Belgium, June 8th 2013 / Optimized Radiochemical Applications (ORA™) today announced that its NEPTIS® plug synthesizer platform has been selected by Eli Lilly and Company as a disposable fluid-path radiosynthesizer used for the production of the radiopharmaceutical product, AMYVID™ (Florbetapir (18F)). In April 2012, AMYVID™ became the first-and-only product of its kind to receive […]
08/06/2013
F-Dopa via new nucleophilic method released on NEPTIS® synthesizer from ORA™
Philippeville, Belgium, June 8th June 2013 / Optimized Radiochemical Applications (ORA™) today announced that a new application for the production of [18F]F Dopa via nucleophilic substitution method and HPLC semi-prep with a preconditioned GMP compliant kit system is now available on its NEPTIS® plug and NEPTIS® perform synthesizer models. Until recently, F-Dopa, a useful radiopharmaceutical […]
08/06/2013
ORA™ reveals in world premiere its new range of innovative NEPTIS® synthesizers for PET radiopharmaceuticals incorporating WNE® system during SNMI-2013
Philippeville, Belgium, June 8th June 2013 / Optimized Radiochemical Applications (ORA™) today announced it is presenting as a world premiere its new range of NEPTIS® synthesizers for the production of PET radiopharmaceuticals incorporating the WNE® system. WNE® system is a unique patented technology allowing the design of 3-position pneumatic actuator, offering more flexibility for complex […]
